1 story in the last 7 days
The latest xortx news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks xortx across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
XORTX Therapeutics voluntarily delists its common shares from the TSX Venture Exchange. The company determined the dual listing did not justify associated costs and administrative requirements. Canadian shareholders will maintain full trading access on Nasdaq. No shareholder action is required.
Summaries by ByteBrief